The FDA Said No. Europe Said Yes. Someone Is Wrong About Camizestrant.
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA and european regulators have made differing decisions regarding camizestrant. The FDA has declined to approve it, while europe has given its approval. The discrepancy between the two regulatory bodies suggests a disagreement over the safety or efficacy of camizestrant.
Full coverage
1
The Washington Post·Jul 32
Life Science Leader·4d ago3
STAT·Feb 124
ChinaTalk·Feb 275
NPR·Nov 296
The New York Times·Feb 187
Consumer Reports·Feb 258
PBS·Sep 5